3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Cystitis, Interstitial
1
Interventions
Specimen Handling
631
pembrolizumab
610
Magnetic Resonance Spectroscopy
553
Carboplatin
450
Cisplatin
398
Cyclophosphamide
397
Biopsy
375
Nivolumab
326
Paclitaxel
324
Gemcitabine
317
Radiotherapy
286
Bevacizumab
244
Dexamethasone
222
fludarabine
215
Docetaxel
199
durvalumab
195
venetoclax
188
Oxaliplatin
187
atezolizumab
184
Fluorouracil
177
Rituximab
176
Pemetrexed
173
Capecitabine
169
Radiation
167
Doxorubicin
166
Radiosurgery
159
Ipilimumab
147
Etoposide
142
Leucovorin
141
Lenalidomide
139
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
chondroitin sulfate, sodium hyaluronate drug combination
×
90 days
×
Clear all
NCT07495072
2026-03-27
PRO-GAG
BLAD-HYA Group
Phase NA
Recruiting
56 enrolled